Infinity Pharmaceuticals Capital Expenditure Trend

INFI -- USA Stock  

USD 1.91  0.07  3.54%

This module enables investors to look at Infinity Pharmaceuticals various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Cost of Revenue of 32.5 M, Interest Expense of 1.6 M or Operating Expenses of 277.9 M, but also many exotic indicators such as Long Term Debt to Equity of 0.2339, PPandE Turnover of 5.4358 or Receivables Turnover of 1 K. This module is a perfect complement to use when analyzing Infinity Pharmaceuticals Valuation or Volatility. It can also complement various Infinity Pharmaceuticals Technical models. Please also check analysis of Infinity Pharmaceuticals Correlation with competitors.
Showing smoothed Capital Expenditure of Infinity Pharmaceuticals with missing and latest data points interpolated. A component of Net Cash Flow from Investing representing the net cash inflow (outflow) associated with the acquisition & disposal of long-lived
Capital Expenditure10 Years Trend
Slightly volatile
 Capital Expenditure 

Regression Statistics

Arithmetic Mean (3,385,061)
Geometric Mean  2,664,579
Coefficient Of Variation (73.71)
Mean Deviation  2,216,292
Median (1,949,000)
Standard Deviation  2,495,105
Range  6,259,000
R Value (0.79)
R Squared  0.62
Significance  0.002293
Slope (545,860)

Infinity Pharmaceuticals Capital Expenditure Over Time

2016-12-31 (6,426,000) 
2017-12-31 (6,426,000) 
2018-12-31 (7,560,000) 

Other Fundumenentals

Thematic Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Infinity Pharmaceuticals Upcoming Company Events

Upcoming Quarterly ReportFebruary 28, 2017
Next Earnings ReportMay 3, 2017
Please also check analysis of Infinity Pharmaceuticals Correlation with competitors. Please also try Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.